Vertex Pharmaceuticals (NQ:VRTX)

517.49 -6.44 (-1.23%)

Delayed Quote Updated: 4:00 PM EDT, Oct 26, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Vertex Pharmaceuticals

< Previous 1 2

...

11 12 13 14 15 16 17 18 19

...

78 79 Next >

Stock Market Rollercoaster: Wall Street Navigates Sharp Swings and Rebounds in Early August

August 05, 2025

The financial markets have been on a tumultuous ride in early August 2025, experiencing a dramatic "see-saw" pattern that has left investors both wary and hopeful. Following a sharp decline at the...

Via MarketMinute

12 Health Care Stocks Moving In Tuesday's Intraday Session ↗

August 05, 2025

Via Benzinga

Which S&P500 stocks have an unusual volume on Tuesday? ↗

August 05, 2025

Let's have a look at the S&P500 stocks with an unusual volume in today's session.

Via Chartmill

Vertex Stock Sinks 12% As Pipeline Setbacks Trigger Wall Street Skepticism: But Retail Sees Opportunity ↗

August 05, 2025

Via Stocktwits

Earnings Scheduled For August 4, 2025 ↗

August 04, 2025

Via Benzinga

Which S&P500 stocks are moving on Tuesday? ↗

August 05, 2025

Join us in exploring the top gainers and losers within the S&P500 index in the middle of the day on Tuesday as we examine the latest happenings in today's session.

Via Chartmill

What's going on in today's session: S&P500 gap up and gap down stocks ↗

August 05, 2025

Wondering what's happening in today's session regarding gap up and gap down stocks? Explore the S&P500 index on Tuesday to uncover the stocks that are gapping in the S&P500 index.

Via Chartmill

Assessing Vertex Pharmaceuticals: Insights From 9 Financial Analysts ↗

August 05, 2025

Via Benzinga

Discover the top S&P500 movers in Tuesday's pre-market session. ↗

August 05, 2025

Stay updated with the S&P500 stocks that are on the move in today's pre-market session.

Via Chartmill

These stocks are moving in today's pre-market session ↗

August 05, 2025

The US market is yet to commence its session on Tuesday, but let's get a preview of the pre-market session and explore the top gainers and losers driving the early market movements.

Via Chartmill

Inspire Medical Systems, Ichor Holdings, Vertex Pharmaceuticals And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session ↗

August 05, 2025

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗

August 05, 2025

Via Benzinga

Why Palantir Technologies Shares Are Trading Higher By Over 5%; Here Are 20 Stocks Moving Premarket ↗

August 05, 2025

Via Benzinga

12 Health Care Stocks Moving In Monday's After-Market Session ↗

August 04, 2025

Via Benzinga

Vertex Pharmaceuticals Stock Dives After Q2 Earnings, Phase 2 Results For VX-993 ↗

August 04, 2025

Vertex Pharmaceuticals announces financial results for the second quarter after the market close on Monday. Here's a rundown of the report.

Via Benzinga

Which stocks are moving after the closing bell on Monday? ↗

August 04, 2025

After the conclusion of the US market's regular session on Monday, let's examine the after-hours session and unveil the notable performers among the top gainers and losers.

Via Chartmill

Vertex Pharmaceuticals Inc (NASDAQ:VRTX) Stock Plummets 13% After Discontinuing VX-993 Despite Q2 Earnings Beat ↗

August 04, 2025

Vertex Q2 2025 earnings beat estimates, but stock dropped 13% after discontinuing acute pain drug VX-993. Focus remains on CF and other key programs.

Via Chartmill

Topics Earnings

Vertex Crashes After Pain Drug Flop Outweighs Second-Quarter Beat ↗

August 04, 2025

Vertex stock crashed late Monday after the company said it wouldn't advance a next-generation pain drug into more testing.

Via Investor's Business Daily

Topics ETFs

Vertex Pharmaceuticals’s (NASDAQ:VRTX) Q2 Sales Beat Estimates But Stock Drops 13.5%

August 04, 2025

Biotech company Vertex Pharmaceuticals (NASDAQ:VRTX) reported revenue ahead of Wall Street’s expectations in Q2 CY2025, with sales up 12.1% year on year to $2.96 billion. The company expects the full...

Via StockStory

Topics Earnings

Vertex Reports Second Quarter 2025 Financial Results

August 04, 2025

From Vertex Pharmaceuticals Incorporated

Via Business Wire

Vertex Announces Results from Phase 2 Study of VX-993 for the Treatment of Acute Pain

August 04, 2025

From Vertex Pharmaceuticals Incorporated

Via Business Wire

Vertex Pharmaceuticals Likely To Report Q2 Profit; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call ↗

August 04, 2025

Via Benzinga

Stock Market Today: US Stocks Likely To Open Higher Despite Weak Jobs Report—Palantir, Vertex Pharma In Focus ↗

August 04, 2025

US stock futures are up on Monday after ending Friday deep in the red, following a disappointing jobs report by Bureau of Labor Statistics.

Via Benzinga

What To Expect From Vertex Pharmaceuticals’s (VRTX) Q2 Earnings

August 02, 2025

Biotech company Vertex Pharmaceuticals (NASDAQ:VRTX) will be reporting earnings this Monday after the bell. Here’s what to look for.

Via StockStory

Topics Artificial Intelligence Economy World Trade

3 Unstoppable Stocks to Buy in August ↗

August 02, 2025

Here are hot stocks to buy in a hot month.

Via The Motley Fool

Topics Intellectual Property

Here's How Much $1000 Invested In Vertex Pharmaceuticals 15 Years Ago Would Be Worth Today ↗

August 01, 2025

Via Benzinga

Examining the Future: Vertex Pharmaceuticals's Earnings Outlook ↗

August 01, 2025

Via Benzinga

2 Top Stocks I Wouldn't Hesitate to Invest $1,000 in Right Now ↗

August 01, 2025

These growth stocks have plenty of room to run.

Via The Motley Fool

The 3 Things That Matter for Vertex Pharmaceuticals Now ↗

July 28, 2025

Some of these developments could improve the company's prospects.

Via The Motley Fool

3 Healthcare Stocks to Buy Before They Announce Game-Changing Clinical Trial Results ↗

July 22, 2025

Via The Motley Fool

< Previous 1 2

...

11 12 13 14 15 16 17 18 19

...

78 79 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.